CONFIDENCE

neoBona brings confidence to parents, from the 10th week of pregnancy it allows the detection of chromosomal abnormalities in the fetus. It is a non-invasive test, with no risk for the future baby.

CLOSE TO YOU

Through SYNLAB, you have access to Europe's largest network of blood collection centres.Here you have the possibility to make an appointment for the test.

Find Location

ACCURACY

Conventional first-trimester screening consists of blood and ultrasound analysis, and provides a statistical index of risk. neoBona directly analyses cell-free fetal DNA and so provides a greater accuracy, better detection, fewer false positives.

SENSITIVITY

Conventional first-trimester screening has a sensitivity of about 90%: out of every 100 fetuses with Down syndrome (trisomy 21), 10 would not be detected (false negative results). The overall sensitivity of neoBona for Down, Edwards and Patau syndromes is higher than 99%.